Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ALKS — Alkermes plc.

CIK 1446194 BALA CYNWYD, PA
Back to ALKS Full portfolio

Position in ALKS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,748,275
+$740,004 QoQ
Shares Held
52,448
-7.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#153
of 424 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Derivatives in ALKS

reported options exposure · as of Jun 30, 2026
CallValue
$7,655,640
CallShares
146,100
PutValue
$17,548,760
PutShares
334,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. ALKS ranks #10 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,504,358 $108,103,165
2 UTHR
UNITED THERAPEUTICS Corp
 88,579 $47,994,759
3 LQDA
Liquidia Corp
 471,067 $37,558,171
4 BCRX
Biocryst Pharmaceuticals Inc
 1,195,651 $11,956,510
5 PRGO
PERRIGO Co plc
 1,149,496 $11,943,263
6 HROW
Harrow, Inc.
 190,116 $8,074,226
7 VTRS
Viatris Inc
 295,261 $4,688,744
8 TLRY
Tilray Brands, Inc.
 1,021,777 $4,587,778

All Filings in ALKS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,748,275 52,448
2026-06-30 $7,655,640 146,100
2026-06-30 $17,548,760 334,900
2026-03-31 $2,008,271 56,795
2026-03-31 $6,789,120 192,000
2026-03-31 $6,994,208 197,800
2025-12-31 $3,332,418 119,100
2025-12-31 $4,073,888 145,600
2025-12-31 $416,146 14,873
2025-09-30 $10,122,000 337,400
2025-09-30 $6,984,000 232,800
2025-09-30 $3,444,330 114,811
2025-06-30 $5,847,569 204,389
2025-06-30 $4,142,728 144,800
2025-06-30 $7,098,141 248,100
2025-03-31 $3,899,662 118,100
2025-03-31 $2,882,646 87,300
2025-03-31 $7,661,465 232,025
2024-12-31 $3,327,733 115,707
2024-12-31 $1,041,112 36,200
2024-12-31 $1,311,456 45,600
2024-09-30 $1,615,023 57,700
2024-09-30 $1,435,887 51,300
2024-09-30 $4,277,179 152,811
2024-06-30 $2,260,580 93,800
2024-06-30 $681,644 28,284
2024-06-30 $600,090 24,900
2024-03-31 $2,742,191 101,300
2024-03-31 $2,404,708 88,833
2024-03-31 $1,518,627 56,100
2023-12-31 $1,392,548 50,200
2023-12-31 $2,305,194 83,100
2023-12-31 $2,450,912 88,353
2023-09-30 $913,126 32,600
2023-09-30 $2,142,765 76,500
2023-09-30 $23,188,917 827,880
2023-06-30 $7,868,820 251,400
2023-06-30 $2,488,350 79,500
2023-06-30 $6,974,797 222,837
2023-03-31 $8,534,747 302,758
2023-03-31 $1,849,264 65,600
2023-03-31 $3,360,248 119,200
2022-12-31 $1,776,840 68,000
2022-12-31 $3,177,851 121,617
2022-12-31 $2,921,334 111,800
2022-09-30 $2,818,046 126,200
2022-09-30 $3,328,018 149,038
2022-09-30 $1,779,701 79,700
2022-06-30 $747,073 25,078
2022-06-30 $560,052 18,800